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Over-activated microglia is involved in various kinds of neurodegenerative process including Parkinson,
Alzheimer and HIV dementia. Suppression of microglial over activation has emerged as a novel strategy
for treatment of neuroinﬂammation-based neurodegeneration. In the current study, anti-inﬂammatory
and neuroprotective effects of the ent-kauranoid diterpenoids, which were isolated from the aerial
parts of Rabdosia japonica (Burm. f.) var. glaucocalyx (Maxim.) Hara, were investigated in cultured
microglia cells. Glaucocalyxin B (GLB), one of ﬁve ent-kauranoid diterpenoids, signiﬁcantly decreased the
generation of nitric oxide (NO), tumor necrosis factor (TNF)-a, interleukin (IL)-1b, cyclooxygenase (COX)-
2 and inducible nitric oxide synthase (iNOS) in the lipopolysaccharide (LPS)-activated microglia cells. In
addition, GLB inhibited activation of nuclear factor-kB (NF-kB), p38 mitogen-activated protein kinase
(MAPK) and generation of reactive oxygen species (ROS) in LPS-activated microglia cells. Furthermore,
GLB strongly induced the expression of heme oxygenase (HO)-1 in BV-2 microglia cells. Finally, GLB
exhibited neuroprotective effect by preventing over-activated microglia induced neurotoxicity in a
microglia/neuron co-culture model. Taken together, the present study demonstrated that the GLB pos-
sesses anti-nueroinﬂammatory activity, and might serve as a potential therapeutic agent for treating
neuroinﬂammatory diseases.
© 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Neuro-inﬂammation mediated by glial activation is identiﬁed as
a common character during progression of many neurodegenera-
tive disorders (1). Microglia, the resident macrophage cells in brain,
are considered to play the key role in regulating neurotoxicity
mediated by inﬂammatory response (2,3). Microglial activation
can be induced by lipopolysaccharide (LPS), interferon (IFN)-g orfax: þ86 512 6588 2089.
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rmacological Society.
g by Elsevier B.V. on behalf of Japa
d/4.0/).b-amyloid in vitro (4). Activated microglia could produce a number
of pro-inﬂammatory factors such as tumor necrosis factor (TNF)-a,
prostaglandins, interleukin (IL)-1b, IL-6 and free radicals such as
nitric oxide (NO) and reactive oxygen species (ROS) (2,4e7). These
neurotoxic factors might lead to neuronal damage, resulting in the
progress of neurodegenerative diseases (4,8). In parallel, excessive
activated astrocytes also aggravate the pathogenesis of neurode-
generative diseases (9,10). Taken together, inﬂammatory activation
of glial cells plays a key role in the pathogenesis of neurodegen-
erative diseases (1,11,12). Therefore, inhibition of glial activation-
mediated neuro-inﬂammation represents an important therapeu-
tic approach to the treatment of neurodegenerative diseases.
Rabdosia japonica (R. japonica) (Burm. f.) var. glaucocalyx
(Maxim.) Hara is recognized as a perennial herb that is widely
grown in East Asia. The aerial parts of R. japonica have been used in
traditional medicine as an antibacterial, anti-inﬂammatory, anti-
cancer, stomachic and anthelmintic agent (13). Glaucocalyxin Anese Pharmacological Society. This is an open access article under the CC BY-NC-ND
P. Gan et al. / Journal of Pharmacological Sciences 128 (2015) 35e4636(GLA)，an ent-kauranoid diterpenoid isolated from the aerial parts
of R. japonica, is known to exhibit various biological activities such
as inhibition of platelet aggregation, anti-oxidative and cytotoxic
activity (14e16). Recently, it was reported that GLA inhibited
expression of pro-inﬂammatory cytokines in microglia cells (17).
However, the structure activity relationship of the ent-kauranoid
diterpenoids as inhibitors of microglia activation and its potential
target remain largely unknown. Here, we report that glaucocalyxin
B (GLB), an analogue of GLA, exerts anti-inﬂammatory effects,
mainly by targeting p38 mitogen-activated protein kinase (MAPK),
nuclear factor-kB (NF-kB) and heme oxygenase (HO)-1 signaling
pathway.
2. Materials and methods
2.1. Reagents and chemicals
LPS was obtained from SigmaeAldrich (St. Louis, MO). Recom-
binant mouse IFN-g was purchased from R&D Systems (Minneap-
olis, MN). Five ent-kauranoid diterpenoids (GLA, GLB, glaucocalyxin
C (GLC), kamebakaurin, minheryins I) (Fig. 1A) were isolated from
the aerial parts of R. japonica as previously described and their
structures were postulated based on the spectral (1H, 13C NMR and
MS) data (18).
2.2. High performance liquid chromatography (HPLC) analysis of
ﬁve ent-kauranoid diterpenoids
Five isolated ent-kauranoid diterpenoids were dissolved in
dimethyl sulfoxide (DMSO), and the concentrations of these diter-
penoids were as follows: GLA 0.997 mg/ml, GLB 0.986 mg/ml, GLC
0.324 mg/ml, kamebakaurin 0.968 mg/ml, minheryins I 1.983 mg/
ml. The purities of compounds (>98%) were detected by HPLC
analysis. The wavelengths used in HPLC were as follows: GLA
230 nm, GLB 230 nm, GLC 210 nm, kamebakaurin 230 nm, min-
heryins I 200 nm (Fig. 1B). The stock solution of these compounds
(100 mM) was dissolved with DMSO.
2.3. Cell culture
BV-2 murine microglia cell, HT22 mouse neuroblastoma cell,
RAW 264.7 macrophage cell and HAPI rat microglia were cultured
in Dulbecco's modiﬁed Eagle's medium (DMEM) supplemented
with 10% fetal bovine serum (FBS), penicillin (0.1%) streptomycin
(0.1%) at 5% CO2, 37 C. Primary astrocytes and microglia cells were
cultured as previously described (19). In brief, 1e2 days newborn
ICR mice were disinfected with 75% alcohol. The skull of mice was
stripped and the whole brain was taken into the dish containing
pre-cooling serum-free DMEM. The pia mater and blood vessels
were carefully removed from cerebral cortex and the desired brain
tissue was washed 2e3 times with precooling serum-free DMEM.
The cortex tissue was cut into 1 mm3 pieces and digested with
papain (2 mg/ml) at 37 C for 30 min. The sample was suspended
using different pore size of tips and then centrifuged for 3 min. The
cells were seeded on poly-D-lysine-coated 75 mm ﬂasks and
cultured for 14 days at 37 C, 5% CO2. The microglia cells were
obtained from mixed glial cultures by shaking at 150 rpm for 2 h.
The astrocytes cultures were separated by shaking at 280 rpm for
12 h. The purity of cultured microglia or astrocytes (>95%) was
determined by immunostaining with antibody of cluster of differ-
entiation 11b (CD11b) or glial ﬁbrillary acidic protein (GFAP),
respectively (data not shown). Animal protocol used in the current
study was approved by Institutional Review Board of Soochow
University. Animal used in the present study was cared under ﬁxed
circadian rhythm with free access to food and water.2.4. Cell viability test
The cell viability was assessed by 3-(4, 5-dimethylthiazol-2-yl)-
2, 5-diphenyltetrazolium bromide (MTT) assay as previously
described (20,21). Cells were seeded in 96-well plates at the density
of 5  104 cells/well. The cell culture supernatant was discarded
after treatment with various agents, and then 30 ml of MTT (0.5 mg/
ml) solution was added into each well. After incubation for 4 h at
37 C, 100 ml of DMSO was added into each well to dissolve the
formazan dye, and then the absorbance of solubilized formazan
was measured by microplate reader.
2.5. Nitrite quantiﬁcation
The generation of NO in the cell culture supernatants was
determined by Griess reagent as described previously (20,21). The
optical density value was detected by microplate reader at 550 nm
of absorbance. NaNO2 was used as the standard to calculate NO2‾
concentrations (22).
2.6. Enzyme-linked immunosorbent assay (ELISA)
The production of TNF-a in the cell culture supernatants was
assessed by TNF-a ELISA kits (R&D Systems, Minneapolis, MN) ac-
cording to manufacturer's instruction (23).
2.7. Quantitative reverse transcription-polymerase chain reaction
(qRT-PCR)
Total RNA was extracted from microglia cells using TRIzol re-
agent (Takara, Dalian, China) and cDNA was prepared from 2 mg of
total RNA using reverse transcription kit (Takara, Dalian, China)
according to the manufacture's instruction. The speciﬁc primers
(Table 1) and SYBR green Premix II kit (Takara, Dalian, China) were
used for qRT-PCR analysis. The comparative threshold cycle (CT)
values of each target gene were normalized to that of GAPDH. The
method was used to analyze the qRT- PCR data as previously
described (24,25).
2.8. Western blot analysis
Forty microgram of proteins from each sample was separated by
SDS-polyacrylamide gel electrophoresis (10%) and transferred onto
polyvinylidene diﬂuoride membranes or nitrocellulose membranes
(Millipore, Bedford, MA, USA). The membrane was blocked with 5%
skim milk, and then incubated with primary antibody. Following
antibodies were used: anti-inducible nitric oxide synthase (iNOS)
and anti-cyclooxygenase (COX)-2 (Abcam, Cambridge, MA); anti-
IkBa, phospho-Іkka, b and phospho-IkBa (Santa Cruz Biotech-
nology, Santa Cruz, CA); anti-ERK1/2, p38, JNK (Cell Signaling
Technology, Beverly, MA); anti-a-tubulin (Sigma). The membrane
was washed with TBST, and then incubated with secondary anti-
bodies (SigmaeAldrich). Finally, the protein bands were visualized
with a ChemiScope 3300 Mini (CLINX, Shanghai, China).
2.9. Measurement of intracellular ROS
Intracellular ROS was detected with dichloro-dihydro-
ﬂuorescein diacetate (DCFH-DA) assay as described previously
(20,21). DCFH-DA was diluted with serum-free culture in 1: 1000.
The cells were collected and suspended in diluted DCFH-DA, and
then incubated at 37 C for 20 min. The plate was shaken every
3e5 min to help the probe to contact cell fully. The cells were
washed by serum-free culture medium for three times in order to
Fig. 1. Chemical structure and HPLC chromatogram of ﬁve ent-kauranoid diterpenoids. HPLC analysis of ﬁve ent-kauranoid diterpenoids conﬁrmed its purity to 96e99 % (GLA 99%,
GLB 98%, GLC 99%, kamebakaurin 99%, minheryins I 96%).
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cytometry (FACScalibur, BectoneDickinson, 488/530 nm).2.10. Establishment of stable BV-2 cell line expressing NF-kB
reporter
BV-2 microglia cells were transduced with NF-kB reporter len-
tiviral particles as previously described (26). Brieﬂy, BV-2 cells were
seeded on 24-well plate and incubated at 37 C for 12 h. Then, NF-
kB reporter lentiviral particles (Cignal™ Lenti Reporters, Qiagen)
were added at a concentration of 2.5  105 transducing units (TU).
Following incubation for 24 h, the supernatant was removed and
replaced with fresh medium. After 2 days, the medium waschanged with fresh medium containing 1.2 mg/ml of puromycin.
After 5 days, surviving cells were selected and used for further
experiments.2.11. NF-kB reporter assay
The BV-2 microglia carrying NF-kB reporter lentiviral particles
were seeded to 24-well plate in triplicate. The cells were pretreated
with GLB or vehicle for 30 min before LPS treatment. After 16 h of
LPS stimulation, luciferase activity was measured using the lucif-
erase assay kit (Promega) according to the manufacturer's in-
struction and the level of promoter activity was expressed as
arbitrary units.
Table 1
Primers used in RT-PCR experiments.
Primer Sequence（50-30)
iNOS Forward:TAGGCAGAGATTGGAGGCCTTG
Reverse:GGGTTGTTGCTGAACTTCCAGTC
COX-2 Forward:CAGGCTGAACTTCGAAACA
Reverse:GCTCACGAGGCCACTGATACCTA
TNF-a Forward:CAGGAGGGAGAACAGAAACTCCA
Reverse:CCTGGTTGGCTGCTTGCTT
IL-1b Forward:TCCAGGATGAGGACATGAGCAC
Reverse:GAACGTCACACACCAGCAGGTTA
gp91phox Forward: CCCAGCAGAAGGTCGTGATT
Reverse: ATCCTGGGCATTGGTGAGTG
p47phox Forward: TGGACGTTGTGGAGAAGAGC
Reverse: GTTCACCTGCGTAGTTGGGA
p22phox Forward: TCCACTTCCTGTTGTCGGTG
Reverse: CACCCTCACTCGGCTTCTTT
HO-1 Forward: AGCCCCACCAAGTTCAAACA
Reverse: CATCACCTGCAGCTCCTCAA
Arg 1 Forward: CCACAGTCTGGCAGTTGGAAG
Reverse: GGTTGTCAGGGGAGTGTTGATG
CD163 Forward:GCTCCTGGAGAAATGAAGAAGGA
Reverse: AGGGCTTTAATAGAAGTTGGGCA
IL-10 Forward: GACCAGCTGGACAACATACT
Reverse: TCTTATTTTCACAGGGGAGA
GAPDH Forward:TGTGTCCGTCGTGGATCTGA
Reverse:TTGCTGTTGAAGTCGCAGGAG
P. Gan et al. / Journal of Pharmacological Sciences 128 (2015) 35e46382.12. Microglia/neuron co-culture
Microglia/neuron co-culture was performed with transwell
insert as reported previously (20). In brief, the microglia cells were
seeded at the density of 5  104 on the transwell insert (pore size
0.4 mm; Corning, CA) in 24-well plates and incubated overnight.
Cells were preincubatedwith GLB for 30min prior to LPS treatment.
After 6 h of LPS treatment, the inserts containing microglia cells
were transferred to HT-22 cells. After co-cultured for 36 h, the in-
serts were removed and the cytotoxicity of HT-22 cells was deter-
mined by MTT assay or AnnexinV/Propidium Iodide (PI) apoptosis
assay.
2.13. Statistical analysis
For multi-group comparison, the data were analyzed by one-
way analysis of variance (ANOVA) followed by the Student New-
man Keul's post hoc method. A value of p < 0.05 was considered
signiﬁcantly different.
3. Results
3.1. ent-kauranoid diterpenoids inhibited LPS induced NO and TNF-
a production in microglia cells
The effect of the ent-kauranoid diterpenoids on LPS-activatedNO
generation in BV-2 microglia cells (Fig. 2A) and primary microglia
cultures (Fig. 2C) was evaluated. Among ﬁve ent-kauranoid diter-
penoids tested, GLA, GLB and kamebakaurin (2.5e10 mM) strongly
decreased LPS-induced NO generation in a dose dependentmanner.
However, GLC and minheryins did not show signiﬁcant inhibitory
effects on NO generation at the same concentration (2.5e10 mM).
The potency of suppression of NO production was ranked based on
50% inhibitory concentration (IC50) as: GLB (4.42 ± 0.15 mM) < GLA
(5.23± 0.23 mM)< kamebakaurin (7.35± 0.17 mM). Cell viability was
measured to exclude the possibility that the decrease of NO gener-
ation was due to the cytotoxicity of the compounds. As shown in
Fig. 2B andD, the compounds did not displayobvious cytotoxicity on
microglia cells. Based on its strong NO inhibitory effects in LPS-activated microglia cells, the anti-inﬂammatory effects of GLB
were further studied. The inhibitory effect of GLB on NO generation
was further conﬁrmed in HAPI rat microglia cells, RAW 264.7 mu-
rine macrophage cells and primary astrocytes (Fig. 3A, B and C). In
addition, we also tested the effect of GLB on TNF-a level in cell cul-
ture supernatant. LPS-induced TNF-a production in BV-2 microglia
or primary microglia was signiﬁcantly decreased by GLB (Fig. 4A
and B).
3.2. GLB inhibited expression of iNOS, interleukin (IL)-1b, COX-2
and TNF-a in LPS-activated microglia cells
To examine the effects of GLB on the gene expression of in-
ﬂammatory mediators in LPS-activated microglia cells, the mRNA
levels of iNOS, TNF-a, IL-1b and COX-2 were determined by qRT-
PCR. GLB signiﬁcantly inhibited mRNA expression of the four in-
ﬂammatory mediators in a dose dependent manner (Fig. 5A, B, C
and D). The inhibitory effects of GLB on protein level of iNOS and
COX-2 in LPS-activated BV-2 microglia cells were also conﬁrmed by
western blot (Fig. 5E).
3.3. GLB inhibited the LPS-induced activation of NF-kВ in microglia
cells
NF-kB is a key transcriptional factor that induces inﬂammatory
cytokines and inﬂammatory enzymes in microglia responses to
inﬂammatory stimuli (27e29). We thus investigated whether NF-
kB pathway was involved in anti-inﬂammatory effects of GLB. LPS
initiates a signaling cascade leading to IkB kinase (Ikk) phosphor-
ylation, followed by IkB phosphorylation, which induce IkB
degradation and translocation of p65 subunit into nuclear. LPS
induced phosphorylation of Ikk a/b, IkB and degradation of IkB
were markedly inhibited by GLB (Fig. 6A). Inhibitory effect of GLB
on LPS-induced nuclear accumulation of p65 and NF-kB luciferase
activity in BV-2 microglia cells was further conﬁrmed (Fig. 6B and
C). MAPKs are upstream signaling molecules in inﬂammatory re-
actions and known to regulate inﬂammatory responses in glial cells
(30e32). Thus, the effect of GLB on the MAPKs (ERK, JNK and p38)
pathways was examined. After stimulation of BV-2 microglia cells
with LPS for 20 min, activation of MAPKs was detected by western
blot analysis using antibody speciﬁc for respective phospho-
MAPKs. The level of p38 phosphorylation was suppressed by GLB,
whereas phosphorylation of ERK and JNK was not altered (Fig. 6D).
These data indicated that the p38 MAPK and NF-kB pathways may
be associated with the anti-inﬂammatory mechanisms of GLB in
microglia cells.
3.4. GLB suppressed the LPS induced intracellular ROS generation
LPS stimulates microglia cells to produce ROS that is associated
with the neuro-inﬂammation and neurodegeneration (33). To test
the effects of GLB on ROS generation, the intracellular ROS was
determined by FACS analysis. As shown in Fig. 7A, GLB reduced ROS
generation in LPS-activated BV-2 microglia cells. Since ROS gener-
ation was mainly catalyzed by NADPH oxidase in microglia cells
(34), the effects of GLB on expression of NADPH oxidase were
examined using qRT-PCR. The results showed that GLB markedly
inhibited expression of gp91phox (Fig. 7B) and p47phox (Fig. 7C) of
NADPH oxidase but not another subunit (p22phox) (Fig. 7D). We
next examined effects of GLB on expression of HO-1, which is an
inducible enzyme that catalyzes the degradation of heme and ex-
erts anti-oxidant and anti-inﬂammatory effects under various
conditions (35). As shown in Fig. 7E, the expression of HO-1 at
transcriptional level was induced by GLB in a dose dependent
manner. Previously, it was demonstrated that HO-1 is actively
Fig. 2. Effect of ent-kauranoid diterpenoids on LPS induced NO generation in microglia cells. Microglia cells were pretreated with compounds for 30 min, and then 0.1 mg/ml of LPS
was added and cultured for 24 h. Nitrite generation in culture media (A, BV-2 cell; C, primary microglia) was determined using Griess reaction. The cytotoxicity of compounds was
determined by MTT assay (B, BV-2 cell; D, primary microglia). Data represent means ± standard deviation (S.D.) of at least three independent experiments. Symbol mark indicates
signiﬁcantly differences from LPS alone treatment group (*p < 0.05, **p < 0.01).
P. Gan et al. / Journal of Pharmacological Sciences 128 (2015) 35e46 39involved in alternative activation of macrophage cells (36). Thus,
the effects of GLB on M2 polarization were evaluated in BV-2
microglia cells. The results showed that GLB did not induce gene
expression for the M2 markers including arginase I (Arg I), IL-10
and CD163 in BV-2 microglia cells (Fig. 8A, B, C).
3.5. GLB suppressed microglial mediated neurotoxicity
Activated microglia could release NO, ROS and various pro-
inﬂammatory mediators such as TNF-a and IL-1b, and thesefactors were believed to contribute to neuronal cell death and
progress of neurodegenerative process (31,32). Inhibition of
microglia activation is an important approach for neuroprotection.
In order to study the potential role of GLB on neuroprotective effect,
a microglia/neuron transwell system was employed. BV-2 cells
were seeded in upper inserts of trans-well chamber and were pre-
incubated with GLB for 30 min before LPS stimulation. After 6 h of
LPS stimulation, cells were washed thoroughly, and then BV-2 cell
on the insert were transferred to HT22 neuroblastoma cells. After
the cells were co-culture for 36 h, the neuroblastoma cell viability
Fig. 3. Effect of GLB on NO generation in activated HAPI rat microglia, macrophage cells and primary astrocytes cells. Microglia cells were pretreated with GLB for 30 min, and then
LPS or LPS/IFN-g was added and cultured for 24 h. Nitrite generation in culture media (A, HAPI cell; B, RAW 264.7 macrophage; C, primary astrocytes) was determined using Griess
reaction. Data represent means ± S.D. of at least three independent experiments. Symbol mark indicates signiﬁcantly differences from LPS alone treatment group (*p < 0.05,
**p < 0.01).
Fig. 4. Effect of GLB on LPS induced TNF-a generation in BV-2 microglia cells (A) or primary microglia cells (B). Microglia cells were pretreated with GLB for 30 min, and then LPS
was added and cultured for 24 h. TNF-a generation in culture media was determined using ELISA kit. Data represent means ± S.D. of at least three independent experiments. Symbol
mark indicates signiﬁcantly differences from LPS alone treatment group (*p < 0.05, **p < 0.01).
P. Gan et al. / Journal of Pharmacological Sciences 128 (2015) 35e4640was analyzed by MTT assay, and cell apoptosis was measured by
ﬂow cytometry. As shown in Fig. 9A and B, pretreatment of GLB
markedly attenuated the cytotoxicity of LPS treated microglia cells
to co-cultured HT22 neuroblastoma cells. The results suggested
that the neuroprotective properties of GLB were attributed to in-
hibition of microglial activation.
4. Discussion
Neuro-inﬂammation caused by activated glial cells is very
important to the development of neurodegenerative diseases (37).
Activated microglia could produce various pro-inﬂammatory cyto-
kines and neurotoxic mediators that contribute to neuronal cell
degeneration (1). In the present study, we compared the effects of
ﬁve ent-kauranoid diterpenoids on the NO generation, and identi-
ﬁed GLB as themost potent inhibitor on LPS-induced NO generation
among ﬁve compounds tested (IC50: GLB < GLA < kamebakaurin),
whereas GLC and minheryins I elicited no inhibitory effects on NO
production (Fig.2). We conﬁrmed that the anti-inﬂammation effect
ofGLAbya recent report (17). GLA,GLB andkamebakaurin containa,b-unsaturated ketone group at C-15, C-16 and C-17, respectively,
while a-orientated hydroxyl group took the place of a, b-unsatu-
rated ketone in GLC (Fig.1A). Minheryins I has a saturated ketone at
C-15 and amethyl groupat C-16 andC-17 (Fig.1A). It appears that the
a, b-unsaturated ketone at C-15, C-16 and C-17 of ent-kauranoid
diterpenoids is themain functional group for the anti-inﬂammatory
action. Acetylatedhydroxyl groupat C-14 inGLB is the only structure
difference from GLA. It is possible that the high liposolubility acetyl
group of GLB made the compound easier to penetrate into the cells,
thereby exhibiting the strongest anti-inﬂammatory properties. In
parallel, the antitumor activity of ent-kauranoid diterpenoids also
exhibited a similar structureeactivity relationship (13). It is known
that NO and PGE2 production were mainly mediated by iNOS and
COX, respectively (38). TNF-a and IL-1b are also important pro-
inﬂammatory mediators, which are actively involved in the pro-
cess of neuroinﬂammatory diseases (1,32). We found that GLB
inhibited TNF-a, IL-1b and COX-2 gene expression at transcriptional
and protein levels in LPS-activated microglia cells. These results
suggested that GLB may be a potential candidate for therapeutic
treatment of neuroinﬂammatory diseases.
Fig. 5. Effect of GLB on LPS induced pro-inﬂammatory genes expression in microglia cells. BV-2 cells were pretreated with GLB for 30 min, and then LPS was added and cultured for
24 h. The mRNA levels of iNOS (A), TNF-a (B), IL-1b (C) and COX-2 (D) were assessed by qRT-PCR. The protein levels of iNOS (E, upper) or COX-2 (E, upper) were assessed by western
blot. The a-tubulin was used as an internal control. Quantiﬁcation of iNOS or COX-2 protein expression was performed by densitometric analysis (E, lower). The values were
expressed as a percentage of maximal band intensity in the LPS alone treated group, which was set to 100%. Data represent means ± S.D. of three independent experiments. Symbol
mark indicates signiﬁcantly differences from LPS alone treatment group (*p < 0.05, **p < 0.01).
P. Gan et al. / Journal of Pharmacological Sciences 128 (2015) 35e46 41LPS initiates signaling cascades for pro-inﬂammatory gene
expression by binding of Toll-like receptor 4 (TLR4). After recog-
nition of LPS by TLR4, a number of intracellular signaling molecules
including IkB kinase (Ikk) complex and MAPKs are activated, and
these cytoplasmic molecules ultimately induce activation of
downstream transcriptional factors including NF-kB and activator
protein (AP)-1 (39). It is well known that NF-kB activation is
regulated by several processes such as Ikk phosphorylation, IkB
phosphorylation, IkB degradation and nuclear translocation of NF-kB. In nuclear, the p65 subunit of the NF-kB complex binds to a kB
site in the DNA region of target genes to regulate gene transcription
(40). In the present study, it was observed that GLB inhibited Ikk
phosphorylation, IkB phosphorylation, IkB degradation and NF-kB
promoter activity in LPS-activated microglia cells. This was
consistent with previous observation that GLA suppressed the
activation of NF-kB (17). In addition to NF-kB, p38 is another critical
modulator of the expression of pro-inﬂammatory cytokines and
enzymes such as iNOS, COX-2, IL-6 and ROS in glial cells (27,38). It
Fig. 6. Effects of GLB on NF-kB activation in activated microglia. BV-2 cells were pretreated with GLB for 30 min, then LPS was added and cultured for indicated times. The levels of
phospho-Ikka, b (5 min), phospho-IkB-a (10 min) and IkB-a (20 min) were assessed by western blot (A). The a-tubulin was used as an internal control. The expression of p65 (1 h) in
nuclear was assessed by western blot (В). The lamin B was used as an internal control. The NF-kB luciferase activity (16 h) was assessed in BV-2 cells stably expressing NF-kB
P. Gan et al. / Journal of Pharmacological Sciences 128 (2015) 35e4642
Fig. 7. Effects of GLB on intracellular ROS generation and expression of NADPH oxidase and HO-1 in microglia cells. BV-2 cells were pretreated with GLB for 30 min, and then LPS
was added and cultured for 4 h. After incubation with 10 mM of DCFH-DA, the generation of intracellular ROS was measured by ﬂow cytometry (A). The mRNA expression of gp91phox
(B), p47phox (C) and p22phox (D) was determined by qRT-PCR. The relative expression value of control group was set to 1. Data represent means ± S.D. of three independent ex-
periments. Symbol mark indicates signiﬁcantly differences from LPS alone treatment group (*p < 0.05, **p < 0.01). The mRNA expression of HO-1 was determined by qRT-PCR (E).
The relative expression value of control group was set to 1. Data represent means ± S.D. of three independent experiments. Symbol mark indicates signiﬁcantly differences from
control group (*p < 0.05, **p < 0.01).
Fig. 8. Effect of GLB on the genes expression of alternative activation marker in BV-2 cells. BV-2 cells were treated with GLB or IL-4 (20 ng/ml) for 6 h. The mRNA levels of Arg 1 (A),
CD163 (B) and IL-10 (C) were assessed by qRT-PCR. The IL-4 treated group was used as positive control for M2 polarization. The relative expression value of control group was set to
1. The data represent means ± S.D. of three independent experiments. Symbol mark indicates signiﬁcantly differences from control group (*p < 0.05, **p < 0.01).
P. Gan et al. / Journal of Pharmacological Sciences 128 (2015) 35e46 43was demonstrated that GLA signiﬁcantly attenuated LPS triggered
activation of p38 (17). In agreement with these results, we also
found that GLB signiﬁcantly inhibited LPS-induced phosphoryla-
tion of p38. The crosstalk between NF-kB and p38 pathways is not
consistent. In the previous study, it was reported that p38 speciﬁc
inhibitor SB 203580 signiﬁcantly blocked NF-kB activation while
NF-kB inhibitor PDTC did not block p38 activation, suggesting that
NF-kB is a downstream signal molecule of p38 in macrophage cells
(41). On the other hand, a number of studies suggested that NF-kBreporter construct (C). The luciferase activity is expressed as relative values and the values
assessed by western blot (D). The total MAPKs were used as an internal control. Quantiﬁca
expressed as a percentage of maximal band intensity in the LPS alone treated group, which w
Symbol mark indicates signiﬁcantly differences from LPS alone treatment group (*p < 0.05and p38 are two independent signal pathways in macrophages
response to inﬂammatory stimuli. In fact, a number of anti-
inﬂammatory agents suppressed NF-kB activation in LPS-
activated microglia cells, whereas p38 activation was not affected
(42e44). Thus, crosstalk between p38 and NF-kB in the regulation
of inﬂammatory response is likely dependent on cell type and na-
ture of stimuli. Although the direct target molecule of GLB is un-
known, this observation indicated that inhibition of NF-kB and p38
MAPK signaling pathway might be involved in molecularof control are set to a relative value of 1. The levels of phosphor-MAPKs (20 min) were
tion of protein expression was determined by densitometric analysis. The values were
as set to 100% (A, B, D). Data represent means ± S.D. of three independent experiments.
, **p < 0.01).
Fig. 9. Effect of GLB on microglia activation mediated neurotoxicity. BV-2 cells were seeded in insert of transwell, and then pretreated with GLB for 30 min before LPS treatment.
After treatment of LPS for 6 h, the inserts were transferred into 24 well plate containing HT-22 neuroblastoma cells and then co-cultured for 36 h. The HT-22 cell viability was
determined by MTT assay (A). The HT-22 cell apoptosis was measured by ﬂow cytometry (B). Data represent means ± S.D. of three independent experiments. Symbol mark indicates
signiﬁcantly differences from LPS alone group (*p < 0.05, **p < 0.01).
P. Gan et al. / Journal of Pharmacological Sciences 128 (2015) 35e4644mechanisms of the suppressive effects of GLB on mRNA expression
of iNOS, COX-2, TNF-a, and IL-1b.
ROS are consistently produced by activated microglia cells and
play a critical role in the inﬂammation-mediated neuro-
degeneration (1,33). Intracellular ROS, as a secondary messenger
for inﬂammatory reactions, activate diverse downstream signaling
molecules including NF-kB, MAPK and protein kinase C (PKC)
(37,45e47), thereby regulating the expression of pro-inﬂammatory
genes in glial cells response to inﬂammatory stimuli. The genera-
tion of ROS was controlled by NADPH oxidase which is a major
source for cellular ROS in LPS-stimulated microglia. There are
growing evidences support that LPS causes upregulation of NADPH
oxidase in microglia cells and inhibition of NADPH oxidase sup-
presses inﬂammatory activation of microglia cells (28,47). NADPH
oxidase was composed of two membrane components (gp91phox
and p22phox) and three cytosolic components (p47phox, p67phox, and
p40phox). Moreover, microglia cells isolated from gp91phox or
p47phox deﬁcient mice showed less production of pro-
inﬂammatory mediators and ROS in cells response to LPS (48). In
the present study, it was observed that LPS-induced ROS generation
and expression of gp91phox and p47phox were signiﬁcantly reduced
by GLB in BV-2 microglia cells. Contrarily, it was reported that GLA,
an analog of GLB, signiﬁcantly elevated ROS generation in human
HL-60 leukemia cells (15). These results suggested that the effect of
glaucocalyxins on the ROS generation may depend on cell type and
concentration of compounds. Since NF-kB and p38 are downstream
of ROS (49,50), inhibition of ROS/NF-kB and ROS/p38 pathways
might be involved in the anti-inﬂammatory mechanisms of GLB.
HO-1 is an inducible enzyme that catalyzes the oxidative
degradation of heme into carbon monoxide, biliverdin, and free
iron (51). Several studies have demonstrated that induction of HO-1
expression in glia cells exhibited anti-inﬂammatory, anti-oxidant
and cytoprotective properties under various conditions (51,52). The
anti-inﬂammatory action of HO-1 in microglia cells was mediated
by inhibition of NF-kB and MAPK signaling pathway (53). In the
present study, we found that GLB signiﬁcantly induced HO-1
expression in microglia cells, suggesting that induction of HO-1
might be involved in the anti-inﬂammatory properties of GLB.
The molecular mechanisms of HO-1 expression are also contro-
versial. Several studies reported that MAPKs, ROS, PKC and NF-kB
signaling play a critical role in the regulation of HO-1 expression
response to oxidative stress (53e55). However, in our work, it wasobserved that GLB alone did not activate MAPK (p38, JNK, ERK) and
NF-kB, indicating that these signaling pathways are not involved in
the GLB induced HO-1 expression in microglia cells. Our previous
study also demonstrated that both NF-kB inhibitor and MAPK in-
hibitor did not induce HO-1 expression in microglia cells, sug-
gesting that these two pathways were not upstream of HO-1 at
least in our experimental conditions (21). Taken together, at least
two pathways are possibly implicated in the anti-inﬂammatory
mechanisms of GLB: 1) NADPH oxidase inhibition mediated sup-
pression of ROS/NF-kB and ROS/p38 activation; 2) HO-1 induction
mediated inhibition of ROS/NF-kB and ROS/p38 activation. Clearly,
further mechanistic studies are required to elucidate the precise
anti-inﬂammatory mechanisms of GLB.
Microglia cells have both beneﬁcial and detrimental function on
neuronal homeostasis (1,56). However, excessive microglial acti-
vation provides neurotoxic microenvironment surrounding neuron
through production of pro-inﬂammatory cytokines and free radi-
cals, contributes to neurodegenerative processes (37,56). Therefore,
inhibition of glial activation can prevent neuronal injuries in
neurodegenerative diseases conditions (57e59). In fact, many anti-
inﬂammatory agents exhibited neuroprotective properties by
inhibiting microglial activation and subsequent production of pro-
inﬂammatory mediators under central nervous system (CNS) dis-
ease conditions (23). In the present study，we found GLB displayed
neuroprotective properties by inhibiting microglial neurotoxicity in
the neuron/microglia co-culture (Fig. 9). Although the LPS-
stimulated microglia/neuron transwell systems may not be the
same as the microenvironments of neurodegenerative diseases, it
partially reﬂects the neuroinﬂammatory conditions in which
neurotoxic factors released by activated microglia cells can induce
neuronal cell apoptosis. However, future studies are required to
identify the precise molecular target of GLB and to evaluate the
neuroprotective effects using proper neuroinﬂammatory disease
animal models. Collectively, the present study demonstrated that
GLB possessed neuroprotective properties by inhibiting microglial
activation, and might have a therapeutic potential against neuro-
inﬂammatory diseases.Conﬂict of interest
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